Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Cuyle PJ"'
Autor:
Ahn, JB, Asselah, J, Badarinath, S, Baijal, S, Begbie, S, Berry, S, Canon, JL, Carbone, RG, Cervantes, A, Cha, YJ, Chang, K, Chaudhry, A, Chmielowska, E, Cho, SH, Chu, D, Couture, F, Cultrera, J, Cunningham, D, Van Cutsem, E, Cuyle, PJ, Davies, J, Dowden, S, Dvorkin, M, Ganju, V, Garcia, RV, Kerr, R, Kim, TY, King, K, Kortmansky, J, Kozloff, M, Lam, KO, Lee, J, Lee, AS, Lesperance, B, Luppi, G, Ma, B, Maiello, E, Mandanas, R, Marshall, J, Marx, G, Mullamitha, S, Nechaeva, M, Park, JO, Pavlakis, N, Ponce, CG, Potemski, P, Raouf, S, Reeves, J, Segal, N, Siena, S, Smolin, A, Streb, JO, Strickland, A, Szutowicz-Zielinska, E, Tabernero, JM, Tan, B, Valera, JS, Van den Eynde, M, Vergauwe, P, Vickers, M, Womack, M, Wroblewska, M, Young, R, Eng, Cathy, Kim, Tae Won, Bendell, Johanna, Argilés, Guillem, Tebbutt, Niall C, Di Bartolomeo, Maria, Falcone, Alfredo, Fakih, Marwan, Kozloff, Mark, Segal, Neil H, Sobrero, Alberto, Yan, Yibing, Chang, Ilsung, Uyei, Anne, Roberts, Louise, Ciardiello, Fortunato
Publikováno v:
In The Lancet Oncology June 2019 20(6):849-861
Publikováno v:
Archives of Clinical and Medical Case Reports.
Pneumatosis intestinalis (PI) is a radiological term to describe the presence of gas in the bowel wall. It can occur as a primary disease or secondary to various other causes ranging from benign conditions to life-threatening diseases. We present thr
Autor:
Martinelli, Erika, Cremolini, Chiara, Mazard, Thibault, Vidal Barrull, Joana, Virchow, I., Tougeron, David, Cuyle, Pieter-Jan, Chibaudel, Benoist, Kim, Stefano, Ghanem, Ismael, Asselain, Bernard, Castagné, Coline, Zkik, A., Khan, S., Arnold, Dirk
Background: BRAFV600E mutations occur in 8%-12% of metastatic colorectal cancer (mCRC) cases and are associated with poor survival. European guidelines recommend combination (doublet or triplet) chemotherapy plus bevacizumab in first line. However, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e1a90e3377ce58b40a1bcb08c9d98a
https://hdl.handle.net/11568/1169763
https://hdl.handle.net/11568/1169763
Autor:
Eric Van Cutsem, Teresa Macarulla, Pascal Hammel, Albrecht Stenzinger, Thomas Seufferlein, Jean-Luc Van Laethem, Eileen M. O'Reilly, Alexander Kleger, Pieter-Jan Cuyle, Joaquim Bellmunt, Estelle Cauchin, Lukas Perkhofer, Tamara Matysiak-Budnik, Johann Gout, Alica K Beutel, Talia Golan
Publikováno v:
Cancers (Basel), 13 (17
Cancers, Vol 13, Iss 4259, p 4259 (2021)
Scientia
Cancers
Cancers, Vol 13, Iss 4259, p 4259 (2021)
Scientia
Cancers
Impaired DNA damage repair (DDR) is increasingly recognised as a hallmark in pancreatic ductal adenocarcinoma (PDAC). It is estimated that around 14% of human PDACs harbour mutations in genes involved in DDR, including, amongst others, BRCA1/2, PALB2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c064448577161c2189c34b51c136bfa
Autor:
Takashima A; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan., García-Alfonso P; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain., Manneh R; Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Beşen AA; Baskent University Medical Faculty, Department of Medical Oncology, Adana, Turkey., Hong YS; Asan Medical Center, University of Ulsan College of Medicine, Seoul, the Republic of Korea., Cuyle PJ; Gastroenterology and Digestive Oncology Department, Imelda General Hospital, Bonheiden, Belgium., Yanez P; Universidad de La Frontera, James Lind Cancer Research Center, Temuco, Chile., Burge M; Royal Brisbane and Women's Hospital, Herston, QLD, Australia., Yoshino T; National Cancer Center Hospital East, Chiba, Japan., Kim TW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, the Republic of Korea., Cui K; AstraZeneca, Gaithersburg, MD, USA., Li C; Merck & Co., Inc., Rahway, NJ, USA., Jain R; Merck & Co., Inc., Rahway, NJ, USA., Adelberg D; Merck & Co., Inc., Rahway, NJ, USA., Taieb J; Georges Pompidou European Hospital, SIRIC-CARPEM, Université Paris Cité, Paris, France. Electronic address: jtaieb75@gmail.com.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Jul; Vol. 205, pp. 114036. Date of Electronic Publication: 2024 Mar 21.
Autor:
Hoorens A; Department of Pathology, UZ Gent, C Heymanslaan 10, 9000 Gent, Belgium., Borbath I; Department of Gastroenterology, Cliniques Universitaires Saint Luc, Brussels,Belgium., Vandamme T; Department of Oncology, UZ Antwerpen, Antwerpen, Belgium., Verslype C; Department of Gastroenterology, UZ Leuven, Leuven, Belgium., Demetter P; Department of Pathology, Jules Bordet Institute, Anderlecht, Belgium., Cuyle PJ; Department of Gastroenterology, Imelda Bonheiden, Bonheiden, Belgium., Ribeiro S; Department of Gastroenterology, UZ Gent, Gent, Belgium., Van Damme N; Belgian Cancer Registry, Sint-Joost-ten-Node, Belgium., Geboes KP; Department of Gastroenterology, UZ Gent, Gent, Belgium.
Publikováno v:
Acta gastro-enterologica Belgica [Acta Gastroenterol Belg] 2023 Apr-Jun; Vol. 86 (2), pp. 345-351.
Autor:
Martinelli E; Medical Oncology, Department of Precision Medicine, Università Degli Studi Della Campania Luigi Vanvitelli, Naples, Italy. Electronic address: erika.martinelli@unicampania.it., Cremolini C; Oncologia Medica, University of Pisa, Pisa, Italy., Mazard T; Institut de Recherche en Cancerologie de Montpellier, INSERM, Montpellier University, Institut du Cancer de Montpellier, Montpellier, France., Vidal J; Department of Medical Oncology, Hospital del Mar - IMIM, CIBERONC, Barcelona, Spain., Virchow I; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Tougeron D; Department of Hepato-gastroenterology, Poitiers University Hospital and University of Poitiers, Poitiers, France., Cuyle PJ; Gastroenterology and Digestive Oncology Department, Imelda General Hospital, Bonheiden, Belgium., Chibaudel B; Department of Medical Oncology, Hôpital Franco-Britannique - Fondation Cognacq-Jay, Levallois-Perret, France., Kim S; Department of Medical Oncology, Centre Hospitalier Régional et Universitaire de Besançon, Besançon, France., Ghanem I; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain., Asselain B; GINECO, Paris, France., Castagné C; Pierre Fabre, Boulogne-Billancourt, France., Zkik A; Pierre Fabre, Boulogne-Billancourt, France., Khan S; Pierre Fabre, Boulogne-Billancourt, France., Arnold D; Asklepios Tumorzentrum Hamburg AK Altona, Hamburg, Germany.
Publikováno v:
ESMO open [ESMO Open] 2022 Dec; Vol. 7 (6), pp. 100603. Date of Electronic Publication: 2022 Nov 08.
Autor:
Jorissen C; Department of Gastroenterology and Hepatology, Imelda General Hospital, Bonheiden, Belgium.; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium., Vertessen A; Department of Gastroenterology and Hepatology, Imelda General Hospital, Bonheiden, Belgium., Bossuyt P; Department of Gastroenterology and Hepatology, Imelda General Hospital, Bonheiden, Belgium.; Imelda GI Clinical Research Center, Bonheiden, Belgium., Cuyle PJ; Department of Gastroenterology and Hepatology, Imelda General Hospital, Bonheiden, Belgium.; Imelda GI Clinical Research Center, Bonheiden, Belgium., Bronswijk M; Department of Gastroenterology and Hepatology, Imelda General Hospital, Bonheiden, Belgium.; Imelda GI Clinical Research Center, Bonheiden, Belgium.
Publikováno v:
Acta gastro-enterologica Belgica [Acta Gastroenterol Belg] 2022 Jan-Mar; Vol. 85 (1), pp. 113.
Autor:
Ahmadi Bidakhvidi N; From the Departments of Nuclear Medicine., Cuyle PJ, Sagaert X; Department of Anatomical Pathology, University Hospitals Leuven, Leuven., Ballaux F; Department of Anatomical Pathology, Imelda Hospital, Bonheiden, Belgium., Deroose CM; From the Departments of Nuclear Medicine.
Publikováno v:
Clinical nuclear medicine [Clin Nucl Med] 2021 Oct 01; Vol. 46 (10), pp. e510-e512.
Autor:
Perkhofer L; Department of Internal Medicine I, Ulm University Hospital, 89081 Ulm, Germany., Golan T; Oncology Institute, Sheba Medical Center, Tel Aviv University, Tel Aviv 52621, Israel., Cuyle PJ; Digestive Oncology Department, Imelda General Hospital, 2820 Bonheiden, Belgium.; University Hospitals Gasthuisberg Leuven and KU Leuven, 3000 Leuven, Belgium., Matysiak-Budnik T; IMAD, Department of Gastroenterology and Digestive Oncology, Hôtel Dieu, CHU de Nantes, 44000 Nantes, France., Van Laethem JL; GI Cancer Unit, Erasme Hospital, Université Libre de Bruxelles, 1070 Brussels, Belgium., Macarulla T; Vall d'Hebrón University Hospital and Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain., Cauchin E; IMAD, Department of Gastroenterology and Digestive Oncology, Hôtel Dieu, CHU de Nantes, 44000 Nantes, France., Kleger A; Department of Internal Medicine I, Ulm University Hospital, 89081 Ulm, Germany., Beutel AK; Department of Internal Medicine I, Ulm University Hospital, 89081 Ulm, Germany., Gout J; Department of Internal Medicine I, Ulm University Hospital, 89081 Ulm, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Van Cutsem E; University Hospitals Gasthuisberg Leuven and KU Leuven, 3000 Leuven, Belgium., Bellmunt J; Medical Oncology, University Hospital del Mar, 08003 Barcelona, Spain.; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Hammel P; Hôpital Beaujon, 92110 Clichy, France., O'Reilly EM; Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Medicine, David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Seufferlein T; Department of Internal Medicine I, Ulm University Hospital, 89081 Ulm, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Aug 24; Vol. 13 (17). Date of Electronic Publication: 2021 Aug 24.